Lyxumia

FDA Staff Questions Usefulness of Sanofi’s Diabetes Drug Combo
FDA Staff Questions Usefulness of Sanofi’s Diabetes Drug Combo
Bloomberg
FDA
Sanofi
diabetes
clinical trials
Lantus
Lyxumia
Flag link:
Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal
Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal
Fierce Pharma
Victoza
Lyxumia
Novo Nordisk
Sanofi
diabetes
GLP-1 agonist
Flag link:
Sanofi's diabetes hopeful Lyxumia gets a raft of good safety grades
Sanofi's diabetes hopeful Lyxumia gets a raft of good safety grades
Fierce Pharma Marketing
Sanofi
diabetes
Lyxumia
Flag link:
Sanofi's diabetes franchise one step closer to U.S. Lyxumia launch
Sanofi's diabetes franchise one step closer to U.S. Lyxumia launch
Fierce Pharma
Sanofi
diabetes
Lyxumia
Flag link:
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?
Seeking Alpha
Lyxumia
GLP-1 agonist
Sanofi
Novo Nordisk
diabetes
Victoza
Flag link:
Sanofi's LixiLan Progresses
Sanofi's LixiLan Progresses
Yahoo/Zacks.com
Sanofi
LixiLan
insulin
Lantus
diabetes
Zealand Pharma
Lyxumia
Flag link:
Sanofi's Lyxumia Gets Japanese Nod
Sanofi's Lyxumia Gets Japanese Nod
Yahoo/Zacks
Sanofi
Lyxumia
Japan
diabetes
Flag link:
Novo Nordisk shares hit by concerns over rival diabetes drugs
Novo Nordisk shares hit by concerns over rival diabetes drugs
Reuters
diabetes
Novo Nordisk
Sanofi
Eli Lilly
dulaglutide
Victoza
Lyxumia
Lantus
Flag link:
Sanofi's New Diabetes Play Moves Forward
Sanofi's New Diabetes Play Moves Forward
Motley Fool
Sanofi
diabetes
Lyxumia
GLP-1 agonist
Flag link:
Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer
Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer
Bloomberg
Lyxumia
diabetes
Zaltrap
colorectal cancer
Flag link:
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer
Bloomberg
Sanofi
Europe
diabetes
Zaltrap
colorectal cancer
Lyxumia
Flag link:
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting
Bloomberg
Sanofi
Lyxumia
diabetes
Bristol-Myers Squibb
Flag link:
Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts
Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts
Motley Fool
Sanofi
Genzyme
Kynamro
Visamerin/Mulsevo
Zaltrap
Lemtrada
Aubagio
Lyxumia
Flag link:
Positive Results for Investigational Compound Lyxumia (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Positive Results for Investigational Compound Lyxumia (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions
Yahoo/PR NewsWire
Lyxumia
diabetes
Sanofi
Flag link:
Sanofi's diabetes drug cuts blood sugar, weight-study
Sanofi's diabetes drug cuts blood sugar, weight-study
Reuters
Sanofi
diabetes
Lyxumia
Flag link: